| 1 |
Which implication can be logically inferred if climate feedback mechanisms are underestimated in predictive models?
|
2. Future climate risks could be systematically underpredicted |
|
Climate feedback mechanisms (like ice–albedo feedback or water vapor feedback) amplify climate change. If models underestimate these feedbacks, they won’t fully capture how strongly the climate can respond to warming—so projections end up being too mild, and future risks are underestimated. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
If current climate models fail to adequately represent cloud–aerosol interactions, which outcome is most likely?
|
3. Misrepresentation of radiative forcing effects |
|
Cloud–aerosol interactions strongly influence how much incoming solar radiation is reflected or absorbed by the Earth (radiative forcing). If climate models fail to represent these interactions accurately, they will misestimate the net cooling or warming effects, leading directly to errors in radiative forcing calculations. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Based on the article’s insights, which scenario would most challenge existing climate adaptation strategies?
|
2. Increased climate variability combined with rapid socio-economic change |
|
Adaptation strategies are usually designed using assumptions about predictable trends and relatively stable social and economic conditions. When climate variability increases |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why does the article suggest that regional climate projections must be interpreted differently from global averages?
|
3. Local feedbacks and vulnerabilities vary significantly |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which factor would most strengthen confidence in long-term climate projections discussed in the article?
|
2. Expanding historical observational datasets |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
From an engineering perspective, which climate insight most directly informs infrastructure design resilience?
|
2. Long-term climate uncertainty ranges |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How does integrating ocean, atmosphere, and cryosphere data improve climate risk assessment?
|
5. By eliminating feedback processes |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
Which conclusion about mitigation efforts is best supported by the article’s analysis?
|
5. Emissions reductions have uniform effects |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Why is transparent communication of uncertainty essential for climate-related decision making?
|
4. It eliminates public misunderstanding |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Based on the article, which research direction would most enhance future climate preparedness?
|
3. Coupled human–Earth system modeling |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
When optimizing CRISPR therapies, which trade-off is most critical to manage?
|
5. Scalability versus laboratory validation |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
If a delivery system triggers a strong immune response, what is the most likely consequence for CRISPR therapy effectiveness?
|
1. Increased gene-editing accuracy |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
Why does the article argue that off-target analysis must be context-specific rather than universal?
|
3. Regulatory standards prohibit customization |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which factor most limits the immediate scalability of CRISPR-based therapies?
|
3. Manufacturing, delivery, and regulatory complexity |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Why are monogenic diseases considered more suitable initial targets for CRISPR therapy development?
|
5. They eliminate delivery challenges |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which consideration most strongly justifies cautious progression to late-stage clinical trials?
|
4. Availability of alternative technologies |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why does the article suggest that CRISPR challenges existing regulatory frameworks?
|
2. It functions as a traditional pharmaceutical |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which ethical concern is most directly linked to the technical capability of CRISPR?
|
5. Intellectual property disputes |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What development would most accelerate responsible clinical translation of CRISPR therapies?
|
5. Limiting long-term follow-up studies |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on the figure and the discussion in the article, which consideration most strongly explains why ex vivo CRISPR-based gene therapy has progressed faster toward clinical translation than many in vivo approaches?
|
5. In vivo CRISPR delivery is technically impossible in human patients |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|